Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Spiro Cyclopropane. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106423281B reveals rare earth silamide catalysis for high-yield spiro compound synthesis, offering cost-effective scalable manufacturing solutions.
Novel phosphorus-promoted synthesis of oxindole spirocyclopropane derivatives offering high purity and scalable production for pharmaceutical supply chains.
Patent CN104803907A enables mild synthesis of spiro-cyclopropanes. Discover cost-effective manufacturing and reliable supply chain solutions for pharmaceutical intermediates.
Patent CN106423281A reveals a novel rare earth silamide catalyst for efficient spiro[cyclopropane-1,3'-indole] synthesis, offering mild conditions and cost reduction.
Novel rare earth silamide catalyzed one-pot synthesis for high-purity spiro[cyclopropane-1,3'-indole] intermediates. Cost-effective and scalable pharma manufacturing.
Patent CN113264816B reveals a catalyst-free sulfur ylide route for spiro[cyclopropane-1,2'-indene]-1',3'-diketones. Achieve high diastereoselectivity and cost efficiency.
Novel patent CN118878537B details cost-effective synthesis. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN110028407B details a novel rare earth catalyzed one-pot synthesis for spiro cyclopropane indene diketones, offering high stereoselectivity and cost-effective manufacturing for global supply chains.
Patent CN118878537A reveals a cost-effective 4-step route for PRMT5 inhibitor intermediates, eliminating palladium catalysts and enhancing supply chain reliability for global pharmaceutical manufacturing.
Patent CN110028407A reveals a rare earth catalyzed method for spiro[cyclopropane-1,2'-indene]-1',3'-dione synthesis offering high stereoselectivity and supply chain advantages.
Patent CN114349704A reveals a novel one-pot synthesis for trifluoromethyl-conjugated pyrazole spirocyclopropanes, offering cost-effective routes for pharmaceutical intermediates.
Patent CN113264816A reveals a base-catalyzed route for high-purity spiro cyclopropane derivatives, offering significant cost reduction in API manufacturing and scalable production.
Patent CN112250614B details a metal-free, one-pot synthesis of 3-spiro-tricyclic indolones using NBS, offering significant cost reduction and scalability for pharmaceutical manufacturing.